Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab versus steroids + cyclophosphamide for idiopathic membranous nephropathy
2011-006115-59Phase 3Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jun 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab, cyclophosphamide in idiopathic membranous glomerulonephritis (IMG), sponsored by ASST Spedali Civili di Brescia. Started Jun 2012; status: active.
02
Drugs
rituximabcyclophosphamide
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on 2011-006115-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006115-59.